Plasmacytoid urothelial carcinoma is rare and aggressive, with poor outcomes and challenges in accurate staging. National and institutional data reveal discrepancies in chemotherapy use and disease ...

Urology in the Lab: Researchers link EBV to multiple sclerosis ...

"We are trying to develop epigenetic biomarkers that can predict patients that are starting to progress to neuroendocrine prostate cancer," says Jindan Yu, MD, PhD. In this video, Jindan Yu, MD, PhD, ...

APPs can significantly alleviate workforce shortages in urology by handling routine clinical tasks, allowing urologists to focus on complex cases. Successful integration of APPs requires changing ...

"There are far more people presenting to us for care than we have people able to provide it. The APPs are going to be a critical part of trying to solve that puzzle," says Mark T. Edney, MD.

Catch up on all the notable drug and device approvals in urology over the past year.

Urology in the Lab: Researchers link EBV to multiple sclerosis ...

Urology in the Lab: Researchers link EBV to multiple sclerosis ...

Panelists discuss how managing overactive bladder in older adults requires a holistic approach that integrates treatment of comorbidities, emerging therapeutic options, and quality-of-life ...

A panelist discusses how significant unmet needs in NMIBC treatment persist around BCG supply shortages, optimal treatment sequencing, biomarker development for patient selection, and reducing ...

Urology in the Lab: Researchers link EBV to multiple sclerosis ...

A full market release of the HYDROS System is expected within the current quarter.